文献速递关节外科

全髋关节置换术后阿片类药物使用的术前危险因素

Preoperative Risk Factors for Opioid Utilization After Total Hip Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

该队列研究纳入2008年至2011年在Kaiser Permanente接受初次择期全髋关节置换术的12,560例患者,评估术前阿片类药物使用及 demographic、合并症等因素与术后1年内每90天阿片处方数的关联。术前阿片处方数增加与整个术后期间处方数增多相关(第271-360天RR 1.10,95%CI 1.10-1.11)。

要点

  • 术后阿片使用率从第1-90天的88.6%降至术后第271-360天的24%。
  • 术前阿片处方数每增加1个,第271-360天阿片处方数RR为1.10(95%CI 1.10-1.11)。

核心结论

  • 研究识别出与全髋关节置换术后早期恢复期之后仍长期使用阿片类药物相关的术前因素。
  • 具有这些危险因素的患者可能从针对性的多学科干预中获益,以降低长期阿片使用的风险。

研究设计与样本

  • 队列研究,纳入2008年1月至2011年12月在Kaiser Permanente接受初次择期全髋关节置换术的患者,共12,560例。
  • 结局为全髋关节置换术后每90天期间(至术后1年)配取的阿片处方数。
  • 评估的危险因素包括术前镇痛药物使用、患者人口学特征、合并症及其他慢性疼痛病史。
  • 采用Poisson回归模型,报告相对危险度(RR)和95%置信区间(CI)。

主要发现

  • 12,560例患者中,58.5%为女性,78.6%为白人,中位年龄67岁(四分位距59-75岁)。
  • 术后阿片使用率从第1-90天的88.6%降至术后第271-360天的24%。
  • 术前阿片处方数增加与整个术后期间阿片处方数增多相关,第271-360天RR为1.10(95%CI 1.10-1.11)。
  • 与整个术后1年使用增多相关的其他因素包括黑人种族、慢性肺病、焦虑、物质滥用和背痛。

关键数值与推荐

  • 术前阿片处方数增加与术后第271-360天阿片处方数增多的RR为1.10(95%CI 1.10-1.11)。
  • 术后第1-90天阿片使用率为88.6%,术后第271-360天为24%。

临床怎么用

  • 对于具有术前阿片使用、黑人种族、慢性肺病、焦虑、物质滥用、背痛、女性、较高体重指数、获得性免疫缺陷综合征、外周血管疾病或非特异性慢性疼痛史等危险因素的患者,可考虑针对性的多学科干预。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid prescriptions following orthopaedic procedures may contribute to the opioid epidemic in the United States. Risk factors for greater and prolonged opioid utilization following total hip arthroplasty have yet to be fully elucidated. We sought to determine the prevalence of preoperative and postoperative opioid utilization in a cohort of patients who underwent total hip arthroplasty and to identify preoperative risk factors for prolonged utilization of opioids following total hip arthroplasty. METHODS: A cohort study of patients who underwent primary elective total hip arthroplasty at Kaiser Permanente from January 2008 to December 2011 was conducted. The number of opioid prescriptions dispensed per 90-day period after total hip arthroplasty (up to 1 year) was the outcome of interest. The risk factors evaluated included preoperative analgesic medication use, patient demographic characteristics, comorbidities, and other history of chronic pain. Poisson regression models were used, and relative risks (RRs) and 95% confidence intervals (CIs) are presented. RESULTS: Of the 12,560 patients who underwent total hip arthroplasty and were identified, 58.5% were female and 78.6% were white. The median age was 67 years (interquartile range, 59 to 75 years). Sixty-three percent of patients filled at least 1 opioid prescription in the 1 year prior to the total hip arthroplasty. Postoperative opioid use went from 88.6% in days 1 to 90 to 24% in the last quarter. An increasing number of preoperative opioid prescriptions was associated with a greater number of prescriptions over the entire postoperative period, with an RR of 1.10 (95% CI, 1.10 to 1.11) at days 271 to 360. Additional factors associated with greater utilization over the entire year included black race, chronic pulmonary disease, anxiety, substance abuse, and back pain. Factors associated with greater utilization in days 91 to 360 (beyond the early recovery phase) included female sex, higher body mass index, acquired immunodeficiency syndrome, peripheral vascular disease, and history of non-specific chronic pain. CONCLUSIONS: We identified preoperative factors associated with greater and prolonged opioid utilization long after the early recovery period following total hip arthroplasty. Patients with these risk factors may benefit from targeted multidisciplinary interventions to mitigate the risk of prolonged opioid use. CLINICAL RELEVANCE: Opioid prescriptions following orthopaedic procedures are one of the leading causes of chronic opioid use; strategies to reduce the risk of misuse and abuse are needed. At 1 year postoperatively, almost one-quarter of patients who underwent total hip arthroplasty used opioids in the last 90 days of the first postoperative year, which makes understanding risk factors associated with postoperative opioid utilization imperative.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Prentice HA, Inacio MCS, Singh A, et al. Preoperative Risk Factors for Opioid Utilization After Total Hip Arthroplasty. J Bone Joint Surg Am. 2019. PMID: 31567804. doi:10.2106/JBJS.18.01005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。